|
期刊名称：AUTOPHAGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Autophagy, is a unique peer-reviewed journal with an international audience that covers the following topics: Macroautophagy, microautophagy, specific organelle degradation (e.g., pexophagy) and additional autophagic processes including chaperone-mediated autophagy; The molecular mechanism of autophagy including the characterization of structural proteins and structure/function relationships; Signaling and autophagic regulation; The role of autophagy in diseases including cancer, neurodegeneration and myopathies; Developmental roles of autophagy and its connection with aging; Autophagy in microbial invasion and the immune response; and Autophagy in cell death.
Autophagy will publish three general types of papers: Original research, reviews, and commentaries. Reviews and commentaries will generally be invited. We propose to cover a wide range of topics in all experimental systems. We also anticipate special issues that are devoted to particular areas of research. Suggestions for appropriate specialized topics will be welcome.
We believe this is an excellent time to start this journal for several reasons:
- Interest in autophagy has increased tremendously as noted by the success of the International Symposium on Autophagy and the Gordon Research Conference on Autophagy in Stress, Development and Disease.
- Autophagy-related publications have dramatically increased in recent years, and the community of autophagy researchers and students similarly grows at a steady pace. A journal devoted to this field will help define and build a community of interested scientists.
- A resource is needed that reflects the increasing importance of autophagy and that provides a venue for the active exchange of information between autophagy research groups worldwide.
- Autophagy will provide a definitive resource that will help promote the field
Instructions to Authors
Guidelines for Authors |
editorial policy | peer review | open access policy
manuscript preparation | manuscript submission | page and color charges
page proofs | reprints
types of papers | references | figures | supplementary files | cover image submissions
|
Editorial Policy
The Editorial Board realizes that many highly selective journals accept only a small fraction of submitted papers; accordingly, even papers of very high quality may not be published in certain journals. Autophagy will reconsider papers that have been rejected by Cell, Developmental Cell, EMBO Journal, Journal of Cell Biology, Journal of Clinical Investigation, Nature, Nature Cell Biology, Nature Medicine, Neuron, Plant Cell and Science, and similar journals, in the original format of those journals, thus saving the authors effort and time. The authors are encouraged to enclose editorial and reviewers' comments from the above-mentioned journals. This will expedite the evaluation of the article; decisions on these papers will generally be made within two weeks. If the paper is accepted for publication in Autophagy, the authors will need to provide the paper in Autophagy format.
Click here for more information regarding our Editorial Policy.
Peer Review
Click here for more information.
Landes Bioscience recognizes that some authors prefer that their research be freely available to all potential readers upon publication, and that certain funding agencies (NIH, Wellcome Trust) request immediate open access of agency-funded research.
To address these requests, we provide the following options for our authors and readers:
(1) One year after publication. ALL papers will become open access to ALL users throughout the world after having been published online for one year.
(2) Immediately upon publication. Papers can be open access immediately upon publication. Authors may purchase open access of their paper at the proof stage and the paper will be made freely available at our website. If the paper is funded by a NIH or Wellcome Trust grant, we will deposit a PDF of the final manuscript with the NIH for download at PubMed Central. The fee for open access is $750. If the author's institution subscribes to the journal the fee is discounted to $500. |
Pre-submission inquiries are not necessary but are welcome. These may include either an abstract or a full length manuscript as an email attachment (Microsoft Word). Pre-submission inquiries should be emailed to the Editor, Daniel J. Klionsky. |
General Submission
We now utilize an online submission and tracking system which is designed to provide a better, more efficient service to authors.
- Authors can submit manuscripts online from anywhere in the world.
- Authors can track their manuscript through the peer review process.
- Author files are automatically converted into a PDF (Portable Document Format) file and submissions are acknowledged by email.
- Editors and reviewers access the PDF files on the website.
|
|
There are no word limits for papers published in Autophagy, however, accepted manuscripts are published with the understanding that the author will pay a charge of $80 USD for pages 5 and greater (there is no charge for the first four pages).
A four page article with three figures (approx 3.5' x 3.5') and 100 references would consist of approximately 3200 words (including figure legends).
Under exceptional circumstances, when no grant or other source of support exists, the author(s) may apply (at the time of submission) to Dr. Dan Klionsky, Editor-in-Chief, for a waiver of the page charges. All applications must be countersigned by an appropriate institutional official stating that no funds are available for the payment of page charges. | |
|
|
Manuscript Preparation
Click here for more information.
Types of Papers
Research Papers should include the following sections:
1. Abstract: A single paragraph of fewer than 250 words. The primary goal of the abstract should be to make the general significance and conceptual advance of the work clearly accessible to a broad readership. References should not be cited in the abstract.
2. Key words: Include 5-10 for indexing purposes.
3. Introduction.
4. Patients and Methods/Materials and Methods: Describe selection of patients or experimental animals, including controls. Do not use patients�names or hospital numbers. Identify methods, apparatus (manufacturer�s name and address), and procedures in sufficient detail to allow other workers to reproduce the results. Provide references and brief descriptions of methods that have been published. When using new methods. Evaluate their advantages and limitations. Identify drugs and chemicals, including generic name, dosage, and route(s) of administration.
Indicate whether the procedures were approved by the Ethics Committee of Human Experimentation in your country, or are in accordance with the Helsinki Declaration of 1975.
5. Results: Present results in logical sequence in tables and illustrations. In the text, explain, emphasize or summarize the most important observations. Units of measurement should be expressed in accordance with Systeme International d�Unites (SI Units).
6. Discussion: Do not repeat in detail data given in the Results section. Emphasize the new and important aspects of the study. Relate observations to other relevant studies. On the basis of your findings (and othersï¿?, discuss possible implications/conclusions. When stating a new hypothesis, clearly label it as such.
7. References: No more than 85.
8. Tables: Tables should be numbered consecutively with Arabic numerals and include descriptive titles and legends.
9. Figure legends.
In addition to basic research studies, Autophagy welcomes papers describing clinical studies that pertain to the field.
Reviews should be recognized as scholarly by specialists in the field being covered, but should also be written with a view to informing readers who are not specialized in that particular field, and should therefore be presented using simple prose. Please avoid excessive jargon and technical detail. Reviews should capture the broad developments and implications of recent work. The opening paragraph should make clear the general thrust of the review and provide a clear sense of why the review is now particularly appropriate. The concluding paragraph should provide the reader with an idea of how the field may develop or future problems to be overcome, but should not summarize the article. To ensure that a review is likely to be accessible to as many readers as possible, it may be useful to ask a colleague from another discipline to read the review before submitting it. Submitted reviews are subject to the same page charges as full-length reports -- whether and how page charges will apply for commissioned reviews will be made clear when each review is commissioned. Reviews should include an abstract of 150 words and should cite no more than 150 references. Please include 5-10 key words for indexing purposes.
Commentaries and Views may be short and focused opinion articles, commentaries on papers recently published in Autophagy or elsewhere, or commentaries on significant conceptual changes, important trends or new directions in the field. These may include figures and up to 30 references. Please include an abstract of 150-200 words and 5-10 key words for indexing purposes.
Addenda are essentially an auto-commentary. The Editorial Board will solicit authors of the most significant recent and forthcoming papers, published elsewhere, to provide a short summary with additional insights, new interpretations or speculation on the relevant topic. These manuscripts may include data or models, which due to space limitations were not included or discussed in the original paper. In other words, the authors may provide biased and uncensored points of views, complementing their article. As with other papers published in Autophagy, addenda will appear on-line, in print and eventually on MedLine/Pubmed. Addenda will appear simultaneously, or very soon after, publication of the original paper.
Please include an abstract of 150-200 words and 5-10 key words for indexing purposes. The citation for the original article including the full author list, title of article and journal information should be included on the title page. The typical length of an addendum will be approximately 500-1,000 words and may include up to 30 references. There will be no page charges for addenda and you are encouraged to include figures; however, please note the journal policy regarding color charges below.
Meeting Reports are summaries of presentations from recent meetings in the field. Authors are encouraged to contact the Editor with proposals for meeting reports. Also, please contact the meeting organizers to verify that reports will be permitted. Please include an abstract of 150-200 words and 5-10 key words for indexing purposes. |
Text Files and Tables
Please save text and table files as Microsoft Word documents. Save tables in a file separate from text. Figure legends, however, should be at the end of the manuscript as text. Tables will be reformatted during production and therefore should only be minimally formatted in your text file.
Figures (Illustrations)
Click here for guidelines on figure preparation and the required formats.
DO NOT EMBED GRAPHICS WITHIN YOUR MS WORD TEXT DOCUMENT.
References
Click here to view our reference format. References for review articles are limited to 150. For Research Papers, please limit references to 85. For Addenda, and Commentaries and Views, please limit references to 30.
The reference format for Autophagy is the same as that for Cell Cycle. Click here to download this output style from EndNotes.
Supplementary Files
Click here for more information.
|
Page and Color Charges
For original research papers that occupy more than four pages of the journal, publication of the first four monochrome pages is free but papers are published on the understanding that the author will pay a charge of $80 U.S. dollars for each additional page or part-page used.
Publication of color images is free for the online version of the journal, but carries a page charge of $340 US dollars for the initial page and $150 for each additional page in the print edition. If you prefer that color figures appear online only and in black and white for the print version, please make sure that the figure legends for each version of the figure are provided.
For guidance, a four page article with 3 figures (approx 9cmx9cm, =3.5" x 3.5") and 100 references would consist of approximately 3200 words of text including figure legends.
Under exceptional circumstances, where there are no funds to cover page charges and articles cannot be reduced in size, authors may appeal directly to the Editor for page charges to be waived. This appeal must be supported by a letter signed by finance official at the author’s institution, confirming that no funds are available to cover page charges.
Page Proofs
Page proofs should be returned within two working days, preferably by email or fax. Corrections should be marked on the actual proof and provided in a numbered list. Lengthy additions should be avoided, but where necessary should be provided in a MS Word file with explicit instructions regarding placement.
Reprints
A reprint order form will be sent to the author prior to the issue going to press or you may download it here. |
|
|
|
| Cover Image Submissions
Autophagy publishes cover illustrations that are taken from articles in each issue, or that are designed to accompany an accepted article.
The cover illustration should be scientifically interesting and visually attractive. The illustration need not be a figure from the paper but should be closely related to the subject of the paper. If you are interested in submitting a figure for use as the cover of Autophagy please email a high-resolution version of your image, conforming to the specifications below, and an explanatory caption of 50-60 words to Kathryn Sauceda.
Autophagy Cover Image Specifications: All potential cover images should be sized to fill the entire cover. 12'' high and 9'' wide should be the minimum size. Larger files are even better. Please remove all text, captions, etc. from the image. If you have variations of the image you may send additional files. Please send no more than 2 alternate versions.
Accepted formats and resolution:
1. Native Photoshop .psd (if graphics are built with layers, do not flatten), 300dpi, CMYK at 100% size.
2. 300 dpi .tif, CMYK at 100% size.
3. 300 dpi highest quality .jpg, CMYK at 100% size.
4. Scalable vector .eps line art or native Illustrator or Freehand files. | download PDF of the journal house style manual |
Editorial Board
|
Editor in Chief |
|
|
University of Michigan; Ann Arbor, Michigan USA |
|
Associate Editors |
|
|
INSERM; Villejuif, France (2005-2008) |
|
|
Albert Einstein College of Medicine; Bronx, NY, USA (2007-2010) |
|
|
University of Texas Southwestern Medical School; Dallas, TX, USA (2005-2008) |
|
|
Tokyo Medical and Dental University; Tokyo, Japan (2007-2010) |
|
|
National Institute for Basic Biology; Okazaki, Japan (2005-2008) |
|
|
University of Groningen; Groningen, The Netherlands (2007-2010) |
|
Editorial Board |
|
|
Hebrew University of Jerusalem; Rehovot, Israel (2007-2010) |
|
|
University of Maryland Biotechnology Institute; College Park, MD, USA (2005-2008) |
|
|
Iowa State University; Ames, IA, USA (2006-2009) |
|
|
University of Pisa; Pisa, Italy (2005-2008) |
|
|
Ordway Research Institute Cancer Center; Albany, NY, USA (2007-2010) |
|
|
Hospital for Sick Children; Toronto, ON, Canada (2007-2010) |
|
|
Linköping University; Linköping, Sweden (2005-2008) |
|
|
Penn State College of Medicine; Hershey, PA, USA (2005-2008) |
|
|
University of New Mexico School of Medicine; Albuquerque, NM, USA (2007-2010) |
|
|
Monash University; Victoria, Australia (2007-2010) |
|
|
Tufts University School of Medicine; Boston, MA, USA (2005-2008) |
|
|
Harvard Medical School; Charlestown, MA, USA (2005-2008) |
|
|
Yale University; New Haven, CT, USA (2006-2009) |
|
|
University of Florida; Gainesville, FL, USA (2005-2008) |
|
|
The Weizmann Institute of Science; Rehovot, Israel (2005-2008) |
|
|
University of California, San Diego School of Medicine; La Jolla, CA, USA (2006-2009) |
|
|
University of Helsinki; Helsinki, Finland (2006-2009) |
|
|
Universityof Basel; Basel, Switzerland (2007-2010) |
|
|
University of Düsseldorf; Düsselfdorf, Germany (2005-2008) |
|
|
The University of Medicine and Dentistry of New Jersey; Piscataway, NJ, USA (2007-2010) |
|
|
Niigattta University; Niigata-City, Japan (2005-2008) |
|
|
Columbia University; New York, NY, USA (2005-2008) |
|
|
Weizmann Institute of Science; Rehovot, Israel (2007-2010) |
|
|
Stanford University School of Medicine; Stanford, CA, USA (2005-2008) |
|
|
Centro de Investigación Príncipe Felipe; Valencia, Spain (2005-2008) |
|
|
Juntendo University School of Medicine; Tokyo, Japan (2005-2008) |
|
|
University of Texas MD Anderson Cancer Center; Houston, TX, USA (2006-2009) |
|
|
Stanford University; Stanford, CA USA (2006-2009) |
|
|
Eötvös Loránd University; Budapest, Hungary (2005-2008) |
|
|
Institut Gustave Roussy; Villejuif, France (2005-2008) |
|
|
University of North Carolina at Chapel Hill; Chapel Hill, NC, USA (2005-2008) |
|
|
Kyusu University; Fukuoka, Japan (2007-2010) |
|
|
University of Shizuoka; Shizuoka, Japan (2005-2008) |
|
|
The Rockefeller University; New York, NY, USA (2007-2010) |
|
|
Novartis Institutes for Biomedical Research Inc. (2006-2009) |
|
|
University of Minnesota; Minneapolis, MN, USA (2006-2009) |
|
|
National Institute of Neuroscience; Tokyo, Japan (2005-2008) |
|
|
New York University School of Medicine, Nathan Kline Institute; Orangeburg, NY, USA (2005-2008) |
|
|
University of Michigan; Ann Arbor, MI, USA (2007-2010) |
|
|
Children's Hospital of Pittsburgh; Pittsburgh, PA USA (2006-2009) |
|
|
University of Cambridge; Cambridge, UK (2005-2008) |
|
|
University of Kiel; Kiel, Germany (2005-2008) |
|
|
Kyoto University; Kyoto, Japan (2005-2008) |
|
|
Institute for Cancer Research; Oslo, Norway (2005-2008) |
|
|
National Academy of Sciences; Lviv, Ukraine (2006-2009) |
|
|
The Norwegian Radium Hospital; Oslo, Norway (2007-2010) |
|
|
University of California, San Diego; San Diego, CA, USA (2005-2008) |
|
|
Columbia University; New York, NY (2006-2009) |
|
|
University of Michigan Medical School; Ann Arbor, MI, USA (2005-2008) |
|
|
Georg-August University; Goettingen, Germany (2005-2008) |
|
|
University of Cambridge; Cambridge, UK (2005-2008) |
|
|
Cancer Research UK; London, UK (2007-2010) |
|
|
Osaka University Graduate School of Medicine; Osaka, Japan (2005-2008) |
|
|
University of Groningen; Groningen, The Netherlands (2005-2008) |
|
|
Washington University School of Medicine; St. Louis, MO, USA (2005-2008) |
|
|
The Cancer Institute of New Jersey; Piscataway, NJ, USA (2008-2011) |
|
|
University of Michigan; Ann Arbor, MI, USA(2006-2009) |
|
|
Osaka University; Osaka, Japan (2005-2008) |
|
|
Fudan University; Shanghai, P.R. China (2007-2010) |
|
|
|
|
